Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ECOR - ElectroCore Inc


Previous close
6.0012
0   0%

Share volume: 681
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$6.00
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
19%
Profitability 18%
Dept financing 22%
Liquidity 36%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
1.42%
1 Month
-1.16%
3 Months
-7.77%
6 Months
-12.55%
1 Year
14.58%
2 Year
-19.33%
Key data
Stock price
$6.00
P/E Ratio 
-2.74
DAY RANGE
N/A - N/A
EPS 
-$2.17
52 WEEK RANGE
$4.90 - $8.08
52 WEEK CHANGE
$0.08
MARKET CAP 
39.004 M
YIELD 
N/A
SHARES OUTSTANDING 
6.447 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
-0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,640
AVERAGE 30 VOLUME 
$9,421
Company detail
CEO:
Region: US
Website:
Employees: 73
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.

Recent news